# Why India rejected a patent application for shorter drug-resistant TB treatment | Explained

https://www.thehindu.com/sci-tech/health/why-india-rejected-a-patent-application-for-shorter-drug-resistant-tb-treatment-explained/article71639506.ece

The decision could open the door to greater generic competition, but its impact on treatment costs will depend on drug availability, pricing, and access to care

Image: https://th-i.thgim.com/public/incoming/fq546f/article71639555.ece/alternates/LANDSCAPE_1200/IMG_Tuberculosis_treatme_2_1_VDD6667R.jpg

---

Canonical URL: https://qwibbit.com/q32632

Created: 2026-10-29T07:58:38.789834+00:00

Last edited: 2026-10-29T07:58:38.789834+00:00

Board: 3

Origin: Syndicated

Original source: https://www.thehindu.com/sci-tech/health/why-india-rejected-a-patent-application-for-shorter-drug-resistant-tb-treatment-explained/article71639506.ece